MedTrace Logo

Clinical Evaluation of the Treatment of Spider Angioma

NCT02755467 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 22

Last updated 2023-03-24

Study results available
· View outcomes & findings →

Summary

To evaluate the safety and effectiveness of the laser treatment for the treatment of spider angiomas.

Conditions

  • Spider Angioma

Interventions

DEVICE

KTP laser

Dual Wavelength Laser Emitting 532 nm Laser Energy

Sponsors & Collaborators

  • Cutera Inc.

    lead INDUSTRY

Principal Investigators

  • Kelly Stankiewicz, MD FAAD · DuPage Medical Group

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
5 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2016-05-26
Primary Completion
2017-01-13
Completion
2017-04-04

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02755467 on ClinicalTrials.gov